Stock Earnings

Question 1

What are Kuros Biosciences AG's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Kuros Biosciences AG has a total asset of $106, Net loss of $-5

Question 2

What are the key financial ratios for CSBTF?

Accepted Answer

Kuros Biosciences AG's Current ratio is 3.31, has a Net margin is -5.31, sales per share of $2.52.

Question 3

How is Kuros Biosciences AG's revenue broken down by segment or geography?

Accepted Answer

Kuros Biosciences AG largest revenue segment is Medical Devices, at a revenue of 75,555,000 in the most earnings release.For geography, United States is the primary market for Kuros Biosciences AG, at a revenue of 72,840,000.

Question 4

Is Kuros Biosciences AG profitable?

Accepted Answer

no, according to the latest financial statements, Kuros Biosciences AG has a net loss of $-5

Question 5

Does Kuros Biosciences AG have any liabilities?

Accepted Answer

yes, Kuros Biosciences AG has liability of 32

Question 6

How many outstanding shares for Kuros Biosciences AG?

Accepted Answer

Kuros Biosciences AG has a total outstanding shares of 37.86

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	118	94	42	22	13	4
Revenue Growth (YoY)	93%	124%	91%	69%	225%	100%
Cost of Revenue	19	10	6	4	3	2
Gross Profit	98	84	35	18	10	1
Selling, General & Admin	92	74	39	19	13	9
Research & Development	8	8	2	3	4	3
Operating Expenses	100	84	42	30	18	13
Other Non Operating Income (Expenses)	--	0	--	--	--	--
Pretax Income	-5	-4	-12	-20	-9	-12
Income Tax Expense	0	0	0	-1	-2	0
Net Income	-7	-5	-17	-18	-7	-11
Net Income Growth	-30%	-71%	-6%	157%	-36%	0%
Shares Outstanding (Diluted)	40.26	37.19	36.58	33.9	32.79	24.31
Shares Change (YoY)	71%	2%	8%	3%	35%	42%
EPS (Diluted)	-0.16	-0.12	-0.47	-0.54	-0.23	-0.47
EPS Growth	-63%	-73%	-13%	135%	-51%	-28%
Free Cash Flow	0	2	-11	-9	-5	-9
Free Cash Flow Per Share	0	0.05	-0.3	-0.26	-0.15	-0.37
Gross Margin	83.05%	89.36%	83.33%	81.81%	76.92%	25%
Operating Margin	-1.69%	0%	-14.28%	-54.54%	-61.53%	-275%
Profit Margin	-5.93%	-5.31%	-40.47%	-81.81%	-53.84%	-275%
Free Cash Flow Margin	0%	2.12%	-26.19%	-40.9%	-38.46%	-225%
EBITDA	1	3	-3	-9	-6	-9
EBITDA Margin	0.84%	3.19%	-7.14%	-40.9%	-46.15%	-225%
D&A For EBITDA	3	3	3	3	2	2
EBIT	-2	0	-6	-12	-8	-11
EBIT Margin	-1.69%	0%	-14.28%	-54.54%	-61.53%	-275%
Effective Tax Rate	0%	0%	0%	5%	22.22%	0%

Kuros Biosciences AG (CSBTF) Price

CSBTF Stock Price Chart

CSBTF Income

Follow-Up Questions